In Vitro Activity of Voriconazole Against Candida Species
- 1 May 1998
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 31 (1), 297-300
- https://doi.org/10.1016/s0732-8893(98)00005-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida kruseiAntimicrobial Agents and Chemotherapy, 1997
- In vitro evaluation of voriconazole against some clinically important fungiAntimicrobial Agents and Chemotherapy, 1997
- Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida speciesAntimicrobial Agents and Chemotherapy, 1997
- In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogensAntimicrobial Agents and Chemotherapy, 1997
- In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida speciesAntimicrobial Agents and Chemotherapy, 1996
- Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistanceThe American Journal of Medicine, 1994
- Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virusAntimicrobial Agents and Chemotherapy, 1994
- Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year periodAntimicrobial Agents and Chemotherapy, 1994
- Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patientsArchives of Internal Medicine, 1984
- Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patientsThe American Journal of Medicine, 1983